Struggling with postpartum depression? Learn about the first FDA-approved pill to treat postpartum depression and find out when it will be available.
The U.S.Food and Drug administrationapproved the first genericLexapro(escitalopram tablets) for the treatment of both depression and generalized anxiety disorder in adults, the government organization announced Wednesday. People with depression typically suffer from feelings of guilt and worthlessness that ...
The U.S. Food and Drug Administration (FDA) late last month approved a medication called Exxua (gepirone) for the treatment of major depression in adults. Gepirone is in the same class of medications as the anti‐anxiety medication buspirone, according to an American Psychiatric Association ...
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression...
On August 19, 2022, the FDA approvedAUVELITY— an oral medication manufactured by Axsome Therapeutics — for the treatment of major depressive disorder (MDD) in adults. This medication provides an additional option for those struggling with MDD who may not be able to use other...
The FDA has approved zuranolone (Zurzuvae, Sage Therapeutics) as the first oral medication to treat postpartum depression (PPD) in adults.1 Prior to this approval, treatment for PPD was only available via intravenous injection administered by a health care provider in specific health care facili...
study, which included 386 participants, aged 22 to 64 years, diagnosed with MDD and onantidepressant medication. Among participants who were randomly assigned to receive either Rejoyn or a sham control app, individuals treated with Rejoyn showed an improvement in depression symptom severity from ...
TheU.S. Food and Drug Administrationhas approved the first pill specifically for the treatment of severe postpartum depression. "Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings," Dr. Tiffany Far...
FDA The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until...
According to the U.S. Food and Drug Administration (FDA), a prescription medicine, which has already been approved for pain management, has been approved in a new medication formulation. The product is called Belbuca and it is a buprenorphine buccal film product (dissolvable medication) that pro...